SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Unlocking the secrets of the fibrotic fortress that surrounds and protects pancreatic cancer

2.

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

3.

Asymptomatic or Minimally Symptomatic Myelofibrosis

4.

New imaging technique identifies glioblastoma patients who would benefit from immunotherapy

5.

How wildfires pose challenges to cancer care


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot